CAS Hub
-
Sponsored by CASCAS explains how intellectual property intelligence enables biologics companies to reduce R&D risk, extend market exclusivity, and unlock commercial value in an increasingly competitive pharmaceutical landscape -
Sponsored by CASCAS examines how AI is changing prior art searches, reshaping intellectual property professional roles, and raising new challenges around data quality, governance, and legal accountability
-
Sponsored by CASThe CAS IP Research Team analyse how organisations are applying IP insights to accelerate scientific breakthroughs and identify potential risks to commercialisation
-
Sponsored by CASPeter Blasi, business development manager at CAS IP Search, explains how to set standards for an effective IP search
-
Sponsored by CASAnne Marie Clark, senior patent searcher at CAS, looks at ways to protect and commercialise the promise of RNAi
-
Sponsored by CASCAS considers how the emerging field of RNA therapeutics highlights trends in targets, chemical modifications, and new delivery systems that increase stability of RNA
